Immediate Impact
1 by Nobel laureates 2 from Science/Nature 54 standout
Citing Papers
Late-stage difluoromethylation: concepts, developments and perspective
2021 Standout
RAS-targeted therapies: is the undruggable drugged?
2020 Standout
Works of Stephen Shuttleworth being referenced
Progress in the Design and Development of Phosphoinositide 3-Kinase (PI3K) Inhibitors for the Treatment of Chronic Diseases
2009
The discovery of GDC-0941: A potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Stephen Shuttleworth | 23 | 34 | 49 | 100 | 64 | 15 | 293 | |
| B.L. Baker | 5 | 64 | 61 | 42 | 34 | 16 | 335 | |
| Philippe Télouk | 1 | 16 | 34 | 16 | 13 | 13 | 281 | |
| P. J. C. Tibbetts | 2 | 13 | 29 | 56 | 56 | 11 | 268 | |
| Rebeca Santamaría-Fernández | 5 | 53 | 116 | 110 | 39 | 19 | 322 | |
| Jaime César | 23 | 65 | 42 | 50 | 20 | 272 | ||
| José Roberto Cerqueira | 2 | 5 | 18 | 82 | 32 | 13 | 217 | |
| W.C. Weimer | 9 | 10 | 45 | 33 | 23 | 21 | 262 | |
| Wei Dai | 9 | 49 | 45 | 22 | 26 | 329 | ||
| Adam H. Love | 11 | 56 | 39 | 14 | 34 | 28 | 315 | |
| Ronald V. Emmons | 2 | 30 | 38 | 97 | 11 | 12 | 333 |
All Works
Loading papers...